A Comparative Study of Coagulation Profile in Normal Pregnancy, Mild Preeclampsia, and Severe Preeclampsia Patients
Sneha Tadu, Karuna Yerroju, Sharmila Gudey
Acute fatty liver in pregnancy, Adverse pregnancy outcome, Coagulation profile in preeclampsia, Disseminated intravascular coagulation, Eclampsia, FFP, Hypertension pregnancy induced, LSCS, Preeclampsia, Preeclampsia profile blood test
Citation Information :
Tadu S, Yerroju K, Gudey S. A Comparative Study of Coagulation Profile in Normal Pregnancy, Mild Preeclampsia, and Severe Preeclampsia Patients. J South Asian Feder Obs Gynae 2023; 15 (1):71-75.
Introduction: Disorders of hypertension complicate approximately 5–10% of all pregnancies. Preeclampsia is a severe health issue that needs to be treated, especially in developing countries where it is more common and its risk of having detrimental effects is higher. This study assessed the severity of preeclampsia and coagulopathy to aid in the management of both situations before patients experienced complications as it is well known that an underlying coagulation disorder increases the risk of bleeding complications.
Aim: The aim of this study was to compare coagulation profile in normal pregnancy, mild preeclampsia, and severe preeclampsia patients.
Results: Preeclampsia patients’ platelet counts were found to be significantly lower, their bleeding times to be noticeably longer, and their D-dimers to be noticeably greater in the current study when they were contrasted with normotensive pregnant women.
Conclusion: The coagulation profile is a crucial tool in the early detection of coagulation failure and its therapy to prevent the situation from getting worse. For a definitive diagnosis and therapy of the coagulation failure in preeclampsia and eclampsia patients, the use of additional parameters such as thrombin time, euglobulin clot lysis time, fibrinogen levels, and fibrinopeptide A is also recommended.
Braunthal S, Brateanu A. Hypertension in pregnancy: Pathophysiology and treatment. SAGE Open Med 2019;7:2050312119843700. DOI: 10.1177/2050312119843700.
Park YH. Diagnosis and management of thrombocytopenia in pregnancy. Blood Res 2022;57(S1):79–85. DOI: 10.5045/br.2022.2022068.
Erez O, Othman M, Rabinovich A, Leron E, Gotsch F, Thachil J. DIC in pregnancy-pathophysiology, clinical characteristics, diagnostic scores, and treatments. J Blood Med 2022;13:21–44. DOI: 10.2147/JBM.S273047.
Bhatia P, Chhabra S. Physiological and anatomical changes of pregnancy: Implications for anaesthesia. Indian J Anaesth 2018;62(9):651–657. DOI: 10.4103/ija.IJA_458_18.
Dado CD, Levinson AT, Bourjeily G. Pregnancy and pulmonary embolism. Clin Chest Med 2018;39(3):525–537. DOI: 10.1016/j.ccm.2018.04.007.
Ilich A, Noubouossie DF, Henderson M, Ellsworth P, Betbadal KF, Campello E, et al. Development and application of global assays of hyper- and hypofibrinolysis. Res Pract Thromb Haemost 2019;4(1): 46–53. DOI: 10.1002/rth2.12275.
Csutak A, Steiber Z, Tőzsér J, Jakab A, Berta A, Silver DM. Plasminogen activator activity in tears of pregnant women. PLoS One 2017;12(5):e0177003. DOI: 10.1371/journal.pone.0177003.
Castaman G, James PD. Pregnancy and delivery in women with von Willebrand disease. Eur J Haematol 2019;103(2):73–79. DOI: 10.1111/ejh.13250.
Fox R, Kitt J, Leeson P, Aye CYL, Lewandowski AJ. Preeclampsia: Risk factors, diagnosis, management, and the cardiovascular impact on the offspring. J Clin Med 2019;8(10):1625. DOI: 10.3390/jcm8101625.
Reese JA, Peck JD, Deschamps DR, McIntosh JJ, Knudtson EJ, Terrell DR, et al. Platelet counts during pregnancy. N Engl J Med 2018;379(1):32–43. DOI: 10.1056/NEJMoa1802897.
Thalor N, Singh K, Pujani M, Chauhan V, Agarwal C, Ahuja R. A correlation between platelet indices and preeclampsia. Hematol Transfus Cell Ther 2019;41(2):129–133. DOI: 10.1016/j.htct.2018.08.008.
Theilen LH, Campbell HD, Mumford SL, Purdue-Smithe AC, Sjaarda LA, Perkins NJ, et al. Platelet activation and placenta-mediated adverse pregnancy outcomes: An ancillary study to the effects of aspirin in gestation and reproduction trial. Am J Obstet Gynecol 2020;223(5):741.e1–741.e12. DOI: 10.1016/j.ajog.2020.05.026.
Jakobsen C, Larsen JB, Fuglsang J, Hvas AM Platelet function in preeclampsia – Asystematic review and meta-analysis. Platelets 2019;30(5):549–562. DOI: 10.1080/09537104.2019.1595561.
Ahmed A, Rezai H, Broadway-Stringer S. Evidence-based revised view of the pathophysiology of preeclampsia. Adv Experiment Med biol 2017;956:355–374. DOI: 10.1007/5584_2016_168.
Grover SP, Mackman N. Intrinsic pathway of coagulation and thrombosis. Arterioscler Thromb Vasc Biol 2019;39(3):331–338. DOI: 10.1161/ATVBAHA.118.312130.
Bikov A, Meszaros M, Schwarz EI. Coagulation and fibrinolysis in obstructive sleep apnoea. Int J Mol Sci 2021;22(6):2834. DOI: 10.3390/ijms22062834.
Hayakawa, M. Pathophysiology of trauma-induced coagulopathy: disseminated intravascular coagulation with the fibrinolytic phenotype. J Intens Care 2017;5:14. DOI: 10.1186/s40560-016-0200-1.
Bhamri, Shailja S. Association of mean platelet volume in the late first trimester of pregnancy and development of preeclampsia. J South Asian Feder Obstet Gynaecol 2018;11(3):172–174. DOI: 10.5005/jp-journals-10006-1672.
Dadhich S, Agrawal S, Soni M, Choudhary R, Jain R, Sharma S, et al. Predictive value of platelet indices in development of preeclampsia. J South Asian Feder Obstet Gynaecol 2012;4(1):17–21. DOI: 10.5005/jp-journals-10006-1164.
Mohapatra S, Pradhan BB, Satpathy UK. Platelet Estimation: Its prognostic value in Pregnancy induced hypertension. Indian J Physiol Pharmacol 2007;51(2):160–164.
Prieto JA, Mastrobattista JM, Blanco JD. Coagulation studies in patients withmarked thrombocytopenia due to severe preeclampsia. Am J Perinatol 1995;12(3):220–222.